[
  {
    "ts": null,
    "headline": "ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell",
    "summary": "ResMed dominates the global sleep apnea device market, boasting a 50â60% share and a high-margin razor-razor-blade business model. See why RMD is a Strong Sell.",
    "url": "https://finnhub.io/api/news?id=d8722ca22c256cc9c1d444521e3180633f6a54a3ac324ba66e1fb07b0a9f8c2e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769907251,
      "headline": "ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell",
      "id": 138321516,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2190893816/image_2190893816.jpg?io=getty-c-w1536",
      "related": "RMD",
      "source": "SeekingAlpha",
      "summary": "ResMed dominates the global sleep apnea device market, boasting a 50â60% share and a high-margin razor-razor-blade business model. See why RMD is a Strong Sell.",
      "url": "https://finnhub.io/api/news?id=d8722ca22c256cc9c1d444521e3180633f6a54a3ac324ba66e1fb07b0a9f8c2e"
    }
  }
]